Influence of dosing time of bazedoxifene in postmenopausal women with osteoporosis
Phase of Trial: Phase IV
Latest Information Update: 08 Feb 2017
Price : $35 *
At a glance
- Drugs Bazedoxifene (Primary)
- Indications Postmenopausal osteoporosis
- Focus Biomarker; Pharmacodynamics
- 07 Feb 2017 Status changed from active, no longer recruiting to completed.
- 07 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 09 Aug 2013 New trial record